Combination Products 2025 took place November 13-14, 2025
Providence, RI
Agenda
The 2026 program is currently in development.
The Combination Products Strategic Committee worked diligently on the 2025 program line-up, carefully reviewing feedback from the previous year and suggestions provided through an open survey to the combination products community. Their focus was to ensure the highest quality discussions, knowledge exchange, and collaboration opportunities.
View a glimpse of what was covered during the 2025 Summit:
Program Topics
Global Harmonization in the Diverging Combination Products Space
EDDO Control Strategies
Digital Health – Application of Good Machine Learning Practices
Clinical Investigations for Combined Use Systems (a global view)
Drug-Delivery Device Clinical Bridging: Leverage Platform Approach and Prior Knowledge
Navigating Human Factors for Combination Products (including Generic: URRA, Threshold Analysis and Post Market)
Navigating the Post-Market Landscape of Combination Products: Surveillance Best Practices, Risk Management and Change Management
Challenges of Supplier and Partner Relationships
Clinical Strategies
View 2025 SessionsLunchtime Table Topics
Hot Topics in Quality
Drug Delivery Systems: Home Use/Self-Administration Labeling Claims
Device-Led Combination Products
Cross-Labeled Products
Submissions
